<DOC>
	<DOC>NCT00055250</DOC>
	<brief_summary>The purpose of this study is to determine the effectiveness and side effects of LY293111 given in combination with gemcitabine in patients with pancreatic cancer.</brief_summary>
	<brief_title>A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Adenocarcinoma of the pancreas that is locally advanced or metastatic and not amenable to resection with curative intent Tumor that can be measured by xray or scan Adequate organ function Inability to swallow capsules Documented brain metastases Prior chemotherapy or biological therapy for this disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>